[Comment] A benchmark for management of drug resistant HIV

20:43 EDT 7 May 2013 | The Lancet

Advances in HIV treatment such as fixed-dose combination pills, which can be taken once a day and have few, well understood side-effects, have helped to change HIV from an inevitably fatal disease to a chronic illness with the prospect of an almost n...

Original Article: [Comment] A benchmark for management of drug resistant HIV

NEXT ARTICLE

More From BioPortfolio on "[Comment] A benchmark for management of drug resistant HIV"

Search BioPortfolio:
Advertisement

Relevant Topic

The top 5 most promising drugs (February 2014)
Latest News Clinical Trials Research Drugs Reports Corporate
THE FIVE MOST PROMISING DRUGS LAUNCHED OR RECEIVING APPROVAL February 2014 Drug Disease Company Gazyva™ Chronic lymphocytic leukemia Biogen Idec/Genentech/ F. Hoffman-La Roche...

Advertisement

Searches Linking to this Story